Par Pharmaceutical Companies Inc. Pleads Guilty, Admits Misbranding Of Megace® Es
Agrees to Pay $45M to Resolve Criminal and Civil Investigations NEWARK, N.J. – New Jersey-based Par Pharmaceutical Companies Inc. (“Par”) pleaded guilty in federal court today and agreed to pay $45…
